0001415889-23-009989.txt : 20230620
0001415889-23-009989.hdr.sgml : 20230620
20230620140131
ACCESSION NUMBER: 0001415889-23-009989
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas John C
CENTRAL INDEX KEY: 0001424620
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39811
FILM NUMBER: 231024459
MAIL ADDRESS:
STREET 1: 8601 SIX FORKS ROAD, SUITE 160
CITY: RALEIGH
STATE: NC
ZIP: 27615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Virios Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818844
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 854314201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
BUSINESS PHONE: 8666208655
MAIL ADDRESS:
STREET 1: 44 MILTON AVENUE
CITY: ALPHARETTA
STATE: GA
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: Virios Therapeutics, LLC
DATE OF NAME CHANGE: 20200721
4
1
form4-06202023_060625.xml
X0407
4
2023-06-15
0001818844
Virios Therapeutics, Inc.
VIRI
0001424620
Thomas John C
C/O VIRIOS THERAPEUTICS, INC.
44 MILTON AVENUE
ALPHARETTA
GA
30009
true
false
false
false
0
Stock Option (right to buy)
1.85
2023-06-15
4
A
0
5250
0
A
2033-06-15
Common Stock
5250
5250
D
The stock option will vest 100% on June 15, 2024, one year following the grant date.
/s/ Greg Duncan, Attorney-in-Fact
2023-06-20